Resolute Capital Asset Partners’s Edgewise Therapeutics EWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-80,003
Closed -$787K 39
2022
Q3
$787K Sell
80,003
-9,187
-10% -$90.4K 0.71% 39
2022
Q2
$710K Buy
+89,190
New +$710K 0.51% 35